2020 Good Quality Palbociclib Ribociclib - Ledipasvir Actone /PVP – CPF

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

abide by the contract", conforms towards the market requirement, joins during the market competition by its good quality likewise as provides additional comprehensive and great services for customers to let them turn out to be big winner. The pursue of your enterprise, is the clients' fulfillment for Doxycycline Mono For Tooth Infection, Doxycycline Monohydrate For Syphilis, Doxycycline Mono Dosage, Normally to the majority of business users and traders to offer best quality goods and excellent company. Warmly welcome to join us, let's innovation collectively, to flying dream.
2020 Good Quality Palbociclib Ribociclib - Ledipasvir Actone /PVP – CPF Detail:

雷迪帕韦丙酮/聚维酮 Ledipasvir actone/PVP 1256388-51-8 In-House
    LPSM1   1256387-87-7 In-House
    LPSM1-5   291775-59-2 In-House
    LPSM2   1129634-44-1 In-House
    LPS-6   1441670-89-8 In-House

Ledipasvir acetone (GS-5885 acetone) is the active ingredient of Ledipasvir. Ledipasvir is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.

In Vitro

Ledipasvir acetone is considered the active ingredient, which is converted to Ledipasvir spray-dried dispersion, an amorphous free base.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

 

Description

Ledipasvir acetone (GS-5885 acetone) is the active ingredient of Ledipasvir. Ledipasvir is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.

 

In Vitro

Ledipasvir acetone is considered the active ingredient, which is converted to Ledipasvir spray-dried dispersion, an amorphous free base.

 

Storage

4°C, protect from light

 

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

 

Chemical structure

Ledipasvir Actone

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

OUR STRENGTH

Quality management1

Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.

Quality management2

Advanced international quality management system has laid solid foundation for sales.

Quality management3

Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect. 

Quality management4

Professional Regulatory Affairs team supports the quality demands during the application and registration.


VIEW MORE


VIEW MORE

International cooperation
International cooperation
Domestic cooperation
Domestic cooperation


Product detail pictures:

2020 Good Quality Palbociclib Ribociclib - Ledipasvir Actone /PVP  – CPF detail pictures


Related Product Guide:

We offer great strength in quality and development,merchandising,sales and marketing and operation for 2020 Good Quality Palbociclib Ribociclib - Ledipasvir Actone /PVP – CPF , The product will supply to all over the world, such as: Ottawa, Sudan, Liverpool, After years of development, we have formed strong ability in new product development and strict quality control system to ensure excellent quality and service. With the support of many long term cooperated customers, our products are welcomed all over the world.
  • We are a small company that has just started, but we get the company leader's attention and gave us a lot of help. Hope we can make progress together!
    5 Stars By Madeline from Guinea - 2017.12.31 14:53
    As an international trading company, we have numerous partners, but about your company, I just want to say, you are really good, wide range, good quality, reasonable prices, warm and thoughtful service, advanced technology and equipment and workers have professional training, feedback and product update is timely, in short, this is a very pleasant cooperation, and we look forward to the next cooperation!
    5 Stars By ron gravatt from luzern - 2017.11.29 11:09
    Write your message here and send it to us